Dr Jorge Palacios drives the research and scientific strategy for Bright Therapeutics, working on leading DTx products such as Recovery Record for eating disorders, Recovery Path for substance use disorders and Moodlinks for depression and anxiety disorders. Following his medical training and PhD from King’s College London in Psychological Medicine, he helped shape and lead research and implementation of digital interventions at SilverCloud Health, through to its acquisition by Amwell. A global advocate for digital therapeutics, his work has been featured in top academic journals, and he speaks widely at international conferences on expanding access and improving engagement with evidence-based digital interventions.

Connect with Jorge on LinkedIn: https://www.linkedin.com/in/dr-jorge-e-palacios/